60 Degrees Pharma Inc

Penny Stocks Pharmaceutical Stocks Healthcare Stocks

$1.12

-0.03 (-2.61%)

As of Aug 9, 11:04 PM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 6 75%

Hold 2 25%

Sell 0 0%

Price Target

Analyst Price Target +137.5% upside

Low Target $2.13

Average Target $2.66

High Target $3.16

Current Price $1.12

Current
$1.12

Target
$2.66

$2.13 $2.66 avg $3.16

Scenario Analysis

Bear Case

$2.13

90.2%

Low target

Base Case

$2.66

+137.5%

Avg target

Bull Case

$3.16

+182.1%

High target

Risk/Reward

2.0x

Favorable

Price in Context

52-Week High

$8.62

-87.0% from high

52-Week Low

$1.05

+6.7% from low

Target vs 52W High

$2.66

-69.1% vs high

Peer Consensus — Pharmaceuticals

Stock	Consensus	Analysts	Buy %	Target	Upside
LLY Eli Lilly and Co.	Strong Buy	38	79%	$1,330.33	+12.2%
RDY Dr. Reddy's Laboratories	Strong Sell	45	31%	—	+0.0%
JNJ Johnson & Johnson	Buy	31	71%	$299.55	+15.5%
MRK Merck & Co. Inc.	Buy	36	69%	$159.27	+23.9%
PFE Pfizer Inc.	Hold	36	39%	$33.90	+26.7%
BMY Bristol-Myers Squibb Co	Hold	35	40%	$174.50	+169.6%
RPRX Royalty Pharma Plc- Cl A	Strong Buy	16	88%	$36.26	-36.1%
ZTS Zoetis Inc	Hold	24	54%	$209.87	+188.8%